Showing results (201-210 of 242) with videos related to
Sort By:
Pageof 25
European Journal of Clinical Pharmacology|January 1, 1989
Influence of renal failure, rheumatoid arthritis and old age on the pharmacokinetics of diflunisalL O Erikson, E Wåhlin-Boll, I Odar-Cederlöf, et al.Pharmacoepidemiology and Drug Safety|April 10, 2004
Socioeconomic factors, morbidity and drug utilization--an ecological studyK Henricson, P Stenberg, G Rametsteiner, et al.European Journal of Clinical Pharmacology|November 16, 1978
Transplacental passage of atenolol in manA Melander, B Niklasson, I Ingemarsson, et al.International Journal of Epidemiology|February 1, 1996
Body mass index and disability pension in middle-aged men--non-linear relationsN O Månsson, K F Eriksson, B Israelsson, et al.Diabetes Care|November 1, 1987
Interaction of ethanol and glipizide in humansS G Hartling, O K Faber, M L Wegmann, et al.European Journal of Clinical Pharmacology|December 14, 1999
Utilisation of codeine and propoxyphene: geographic and demographic variations in prescribing, prescriber and recipient categoriesK Henricson, A Carlsten, J Ranstam, et al.Diabetes, Obesity & Metabolism|August 25, 2001
Differences in pharmacotherapy and in glucose control of type 2 diabetes patients in two neighbouring towns: a longitudinal population-based studyJ Olsson, G Lindberg, M Gottsäter, et al.Clinical Pharmacology and Therapeutics|July 1, 1977
Enhancement of hydralazine bioavailability by foodA Melander, K Danielson, A Hanson, et al.European Journal of Clinical Pharmacology|January 1, 1992
Large intercommunity difference in cardiovascular drug consumption: relation to mortality, risk factors and socioeconomic differencesM Oreberg, G G Jonsson, K West, et al.Diabetologia|June 16, 2000
Increased mortality in Type II diabetic patients using sulphonylurea and metformin in combination: a population-based observational studyJ Olsson, G Lindberg, M Gottsäter, et al.Pageof 25